Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

zinc

NULL

zinc (NULL) is a blocks absorption of copper and induces the production of the copper-binding protein metallothionein..

EMA: approved TGA: approved Alimentary tract and metabolism (A16) A16AX05
Patents linked 20
Pipeline programs 7
News articles 1
Drug details — zinc
Class
Alimentary tract and metabolism (A16)
Route
—
Patents
20
Programs
7
Data quality
0.83
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

zinc (NULL) is a blocks absorption of copper and induces the production of the copper-binding protein metallothionein..

Key facts

INN zinc
Brand NULL
Mechanism Blocks absorption of copper and induces the production of the copper-binding protein metallothionein.
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AX05

Mechanism of action

Blocks absorption of copper and induces the production of the copper-binding protein metallothionein.

Approval history

Authority Status Date
EMA approved —
TGA approved —

Recent coverage

View all news
Axsome FDA Approval for Alzheimer's Agitation Drug
Critical impact Newsagitation associated with Alzheimer's diseaseMay 3, 2026

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

Axsome Therapeutics has received FDA approval for a new treatment for agitation associated with Alzheimer's disease. This landmark decision addresses a critical unmet need and marks a significant step forward for the company and Alzheimer's patient care.

Dr. Priya Nandakumar

Pipeline programs

Browse pipeline
  1. Zinc sulphate Phase 3 · United Therapeutics Europe · Diarrhea
  2. Zinc sulphate 20 mg Phase 3 · United Therapeutics Europe · Bronchiolitis
  3. zinc sulphate dietary supplement Phase 3 · United Therapeutics Europe · Nutrition
  4. zinc supplementation Phase 2 · United Therapeutics Europe · HIV Infections
  5. iron and zinc combined Approved · United Therapeutics Europe · Anemia
  6. Zinc gluconate Unknown · Grace Therapeutics · HIV
  7. zinc Unknown · BRIGHT MINDS BIOSCIENCES · HIV Infections

Related & competitor drugs

Browse all drugs
  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Related patents

Browse patents

  1. US 12077551

    Zinc complex, preparation thereof and use thereof for trerapy of human and animal diseases

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11713305

    Zinc sensors for in vivo imaging of beta-cell function by MRI

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11421007

    Zinc finger protein compositions for modulation of huntingtin (Htt)

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11267832

    Mn(II)-based sensors to detect zinc in vivo with MRI

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11125741

    Compositions and methods for the detection of zinc

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9897595

    Compositions and methods for the detection of zinc

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9757209

    Compositions and methods for dental applications involving zinc-oxide cements

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9717759

    Modification of CXCR4 using engineered zinc finger proteins

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9624498

    Methods and compositions for regulation of zinc finger protein expression

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9284251

    Complex zinc and alpha-chlorocarboxylic acid compounds for treating skin lesions

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9234016

    Engineered zinc finger proteins for treating trinucleotide repeat disorders

    Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9163245

    Compositions for linking zinc finger modules

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8975295

    Modulation of zinc levels to improve tissue properties

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8871905

    Modification of CXCR4 using engineered zinc finger proteins

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8771985

    Genome editing of a Rosa locus using zinc-finger nucleases

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8772453

    Compositions for linking zinc finger modules

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8680021

    Zinc finger proteins for DNA binding and gene regulation in plants

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8466267

    Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8313925

    Zinc finger proteins and method for inactivating a dhfr gene in a chinese hamster ovary cell

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7705139

    Zinc finger proteins for DNA binding and gene regulation in plants

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is zinc?

zinc (NULL) is a blocks absorption of copper and induces the production of the copper-binding protein metallothionein..

What is the brand name for zinc?

NULL is a marketed brand name for zinc. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.